This conference is a continuation of the Fibroblast Growth Factors in Development and Repair series with an expanded scope that includes other growth factors and cytokines that are involved in tissue repair and regeneration/regenerative medicine.
The Growth Factors in Regeneration and Regenerative Medicine Fusion Conference aims to bring together researchers and clinicians from different disciplines with an interest in the function of growth factors in tissue regeneration and their use for regenerative medicine. This meeting will provide a unique opportunity for academic and industrial researchers and clinicians to meet each other, to discuss projects, and to initiate new and in some cases highly interdisciplinary research projects and collaborations.
• Role of growth factors in stem cell biology
• Extracellular matrix regulation of growth factor signalling in tissue repair and regeneration
• Vasculature in tissue repair and regeneration
• Immune system in repair and regeneration
• Growth factor function in tissue repair vs. cancer
• Growth factor-based tissue engineering for repair and regeneration
Take advantage of this fantastic opportunity for students! Register an academic at the early bird rate and bring a student for only $870. Unfortunately, Postdocs are not eligible. Both registration packages include; accommodation for the 11, 12, 13 Feb 2021 (on a shared basis for students) and a food and beverage package for the conference period. Academic registrations must be completed by 27 August 2020. Once registered, please contact (Amy Johnson) to obtain a special registration link for your student.
Growth factors control survival, proliferation, migration, metabolic functions and the gene expression program of all cells in the body. Upon injury, expression of many growth factors is upregulated, thereby stimulating proliferation and migration of cells at the site of injury. The correct interplay among different growth factors and their cross-talk with other injury-relevant signals is crucial for normal repair. While certain lower organisms have a strong regenerative capacity and can even regenerate complete amputated limbs, this capability is rudimentary in mammals where tissue injury most often results in scar formation with functional and aesthetical impairment. Therefore, there is a strong need to develop strategies to improve the repair/regeneration process. A detailed understanding of growth factor function in regenerating vs non-regenerating tissues and organisms will help to design such strategies. Based on this knowledge, the application of growth factors to injured tissues or activation of major growth factor signaling pathways has a strong potential to improve tissue regeneration. Such approaches require not only the design of suitable molecules, but also their appropriate delivery. All these aspects will be addressed at the Fusion Conference. The meeting is therefore of major interest for cell and developmental biologists, researchers and clinicians working in the area of tissue repair and regeneration, pharmacologists and bioengineers. We expect this meeting to attract people from academia, but also from various Biotechnology and pharmaceutical companies.
Growth factor research as well as tissue repair research are well represented at different places in the world, with major hubs in Europe, in the US, and in China. However, researchers from other countries also join such conferences.
Confirmed Invited Speakers:
Sabine Eming (University of Cologne)
Jeff Hubbell (University of Chicago)
Luisa Iruela-Arispa (Northwestern University Chicago)
Mike Longaker (Stanford University)
Paul Martin (University of Bristol)
Andrew McMahon (University of Southern California)
Helen McNeill (Washington University)
Kristy Red-Horse (Stanford University)
Michael Rudnicki (Ottawa Hospital Research Institute)
Maria Sibilia (Medical University Vienna)
Dietmar Vestweber (Max-Planck-Institute for Molecular Biomedicine)
Rusty Williams (Walking Fish Therapeutics)
Thomas Wynn (Pfizer)
Research on Growth Factor signalling pathways in stem cell biology, as mediators of tissue injury, and as potential therapeutics in regenerative medicine is rapidly progressing. Because of the rapid progress in these clinically relevant areas, there is a critical need to bring together researchers from academia and from the Biotechnology and Pharmaceutical industries, and clinicians, to share ideas and establish collaborations. There is an additional need to educate new researchers on the recent progress in understanding growth factors as mediators of disease and their use as therapeutics for regenerative medicine.